Approval · Notice of Compliance 9232 · 2007
VIVAGLOBIN: Notice of Compliance 9232
Issued December 7, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9232
- Date
- December 7, 2007
- Company
- Csl Behring Canada IncOttawa, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Qualification of an alternate drug substance intermediate
- Therapeutic class
- Passive immunization agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VIVAGLOBIN | Not yet assigned | — |
Medicinal ingredients
- IMMUNOGLOBULIN G (HUMAN) 160 MG per ML